South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
Skip to content
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
Attridge, Aspen’s group chief advisor who ranks as one of JSE’s richest investors, owns a 4.26-percent stake in the pharma group.
The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 and Oct. 26.
At the helm of Aspen Pharmacare, Attridge has made significant contributions to Africa’s healthcare sector.
Apart from his executive and governance roles in Aspen Pharmacare, Attridge owns a notable 4.28-percent stake in Aspen.
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
Attridge, Aspen’s group chief advisor, owns a 4.26-percent stake in the pharmaceutical company.
South African executive Michael Guy Attridge (Gus Attridge) has witnessed a remarkable year-to-date gain of more than $55 million from his stake in Aspen Pharmacare
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharma company.
Attridge owns a 4.26-percent stake in the company.
Aspen Pharmacare is a multinational pharmaceutical holding company.